Re: General13 Feb 2019 17:43
@markthemango1
Hopefully, either a buyout or the funding from rights of the topical pain relief will see us over the line. On selling shares at a profit, one has to remember that LO lost a packet on their original holding. The average cost of their purchases up to 2016 was around 42p. In 2016 they subscribed to a placing at 57p. In 2018 they made disposals at 36p, 17p, and 8p! Why they disposed of 6 million shares in early November at around 8p I do not know. Beancounters may look at this differently, but in terms of cash, if LO were to sell their holding of 38 million shares today, they would be out of pocket. Now their exposure is below £10 million, and their holding is back to 18% odd of shares in issue, I expect the selling to abate. Also the newsflow for the next few weeks may be thin.